Red Light Holland Corp. Stock OTC Markets

NFCPF

CA6651582000

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

05-25	Red Light Holland and Allu Therapeutics Expand Supply Agreement to Include Filament Health's Gmp-Compliant Pex010 Botanical Psilocybin Drug Candidate	CI
05-13	Red Light Holland Receives Shareholder Approval of Name Change; Keith Li to Resign as CFO	MT

Valuation: Red Light Holland Corp.

Market Cap	10.64M 7.6M 6.64M 6.13M 5.65M 732M 10.88M 73.22M 28.8M 358M 28.53M 27.9M 1.23B	P/E 2024	-3.11x	P/E 2025	-2.98x
Enterprise Value	-226K -161K -141K -130K -120K -15.51M -231K -1.55M -611K -7.6M -605K -592K -26.16M	EV / Sales 2024	2,135,477x	EV / Sales 2025	294,702x
Free-Float	-	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Red Light Holland Corp.

05-25	Red Light Holland and Allu Therapeutics Expand Supply Agreement to Include Filament Health's Gmp-Compliant Pex010 Botanical Psilocybin Drug Candidate	CI
05-13	Red Light Holland Receives Shareholder Approval of Name Change; Keith Li to Resign as CFO	MT
05-13	Red Light Holland Corp. Announces Resignation of Keith Li as Chief Financial Officer	CI
05-08	Red Light Holland Corp. Expands Pharmaceutical-Grade Manufacturing, Regulatory, and Clinical Research Capabilities	CI
04-28	Red Light Holland Corp. completed the acquisition of Filament Health Corp. (OTCPK:FLHL.F) from from Benjamin Lightburn and Negev Capital Fund One L.P. Fund, managed by Negev Capital for CAD 4 million.	CI
04-24	Red Light Holland Corp And Filament Health Corp Showcase Growing Clinical Demand For PEX010 With New And Repeat University Shipments	CI
04-21	Red Light Holland Corp. to Advance with Materially Stronger Regulatory and Commercial Momentum Through Landmark Executive Order by U.S. President Donald J. Trump	CI
04-20	Red Light Holland Corp Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy Using Filament Health's Patented PEX010 Botanical Drug Candidate	CI
03-09	Red Light Holland Corp. entered into a letter of intent to acquire Filament Health Corp. (OTCPK:FLHL.F) from Benjamin Lightburn and Negev Capital Fund One L.P. Fund, managed by Negev Capital for CAD 2.8 million.	CI
03-02	Red Light Holland Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
12-01	Red Light Holland Corp. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-19	Red Light Holland's FDA -Compliant, DEA- Registered Partner Irvine Labs Receives Second, Larger 5Kg Psilocybin Shipment Via USA Controlled Substances Import Permit	CI
25-10-14	Red Light Holland Corp. Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA- Compliant, DEA-Registered Partner Irvine Labs	CI

More news

Last Transcript: Red Light Holland Corp.

Red Light Holland Corp., 2025 Earnings Call, Jul 30, 2025

25-07-30

More transcripts

Press Releases: Red Light Holland Corp.

07-17	Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp	NE
07-16	Red Light Holland Announces New Filament Health PEX010 European Research Shipment	NE
07-08	Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offering the Widest Standardized Dosing Range, from 0.5 mg to 25 mg	NE
07-07	Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre	NE
06-18	Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health	NE

More press releases

Managers and Directors: Red Light Holland Corp.

Manager	Title	Age	Since
Todd Shapiro CEO	Chief Executive Officer	-	2020-05-21
Benjamin Lightburn PSD	President	40	-
Ka Yin Li DFI	Director of Finance/CFO	46	2025-01-21

Director	Title	Age	Since
Todd Shapiro CHM	Chairman	-	1982-09-28
Brad Lamb CHM	Chairman	-	2020-05-24
Binyomin Posen BRD	Director/Board Member	31	2019-02-28

More insiders

Red Light Holland Corp. is a Canada-based company. The Company is engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal recreational market within the Netherlands. Its subsidiaries include RLH Netherlands BV, RLH Farms BV, Red Light Holland (Subco 1) Inc., SR Wholesale B.V., Red Light Acquisition Inc., and Radix Motion Inc., among others. Its product line consists of the iMicrodose kit, Maka Magic Truffles, Home Grow Mushroom Kits, MisterCap, and Wisdom Truffle, among others. The Maka magic truffles line, including the Hollandia, Makanaut, Muskoka, Mexicana, Atlantis, Double Vision, Old Dutch and Utopia varieties, is designated as a Responsible Use Psychedelic. Wisdom Truffle is a smart figurine that helps people build healthy patterns using meditation, monitor their phone usage, and take positive action to reduce their carbon footprint.

Employees

Sector

More about the company

Income Statement and Estimates

More financial data

	2024	2025
Net sales	4.75 3.39 2.96 2.74 2.52 326.64 4.86 32.69 12.86 159.98 12.74 12.46 550.71	4.94 3.53 3.08 2.85 2.62 339.87 5.05 34.02 13.38 166.45 13.25 12.96 573.01
Net income	-7.63M -5.44M -4.76M -4.39M -4.05M -524M -7.8M -52.47M -20.64M -257M -20.45M -20M -884M	-4.04M -2.89M -2.52M -2.33M -2.14M -278M -4.13M -27.81M -10.94M -136M -10.84M -10.6M -468M
Net Debt	-13.48M -9.62M -8.41M -7.76M -7.15M -927M -13.78M -92.74M -36.48M -454M -36.13M -35.34M -1.56B	-10.87M -7.76M -6.78M -6.26M -5.77M -747M -11.11M -74.77M -29.41M -366M -29.13M -28.49M -1.26B